Cellectis S.A. Share Price Other OTC
Equities
CMVLF
FR0010425595
Biotechnology & Medical Research
Sales 2024 * | 1.62Cr 1.76Cr 146.99Cr | Sales 2025 * | 7.06Cr 7.68Cr 640.72Cr | Capitalization | 20Cr 22Cr 1.8TCr |
---|---|---|---|---|---|
Net income 2024 * | -7.4Cr -8.05Cr -671.82Cr | Net income 2025 * | -7.1Cr -7.73Cr -644.59Cr | EV / Sales 2024 * | 12.2 x |
Net cash position 2024 * | 6L 6L 5.2Cr | Net cash position 2025 * | 18Cr 20Cr 1.63TCr | EV / Sales 2025 * | 0.26 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Cellectis S.A.
Managers | Title | Age | Since |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 20/99/20 |
André Choulika
FOU | Founder | 59 | 20/99/20 |
Arthur Stril
DFI | Director of Finance/CFO | 35 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 05/20/05 | |
André Choulika
FOU | Founder | 59 | 20/99/20 |
David Sourdive
FOU | Founder | 57 | 20/99/20 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 4.92TCr | |
+1.00% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.68% | 2.61TCr | |
-22.99% | 1.87TCr | |
+8.22% | 1.33TCr | |
+32.41% | 1.23TCr | |
-1.62% | 1.2TCr |